Pharmaceuticals
Latest news, explainers and analysis on Pharmaceuticals. Tracking 11 stories on Arth Vani.
Connected in the graph
Latest on Pharmaceuticals
Panmure Sees Further Growth for Hikma After Recent Stock Rally
Analyst firm Panmure believes that pharmaceutical company Hikma's stock recovery story still has more potential for growth, even after its recent rally. This outlook suggests a continued positive trajectory for the global company's shares.
Indian Biotech Sector Booms as Startup Count Hits 2,400; PE Investments Double
India's pharmaceutical and biotech landscape is witnessing a massive shift with private equity investments doubling to $731 million. A new report highlights that the number of biotech startups has surged to 2,400, signaling a robust pipeline for new drug development.
Dr. Reddy's Semaglutide Supply Faces Delay, No Recall Risk
Dr. Reddy's Laboratories has announced a delay in the supply of its Semaglutide, a key diabetes and weight-loss drug. The company clarified that this is a supply chain issue and not related to any quality concerns or a product recall.
Sun Pharma Shares Register Weekly Growth, Signalling Positive Investor Mood
Sun Pharmaceutical Industries Ltd. shares have shown positive movement over the past week, indicating a favourable sentiment among investors. This weekly growth is a key point of interest for those tracking the pharmaceutical sector and Sun Pharma's market performance. It suggests increased buying interest for the company's stock.
Sun Pharma Shares Slip Below Key Technical Support; Analysts Monitor Short-Term Weakness
India's largest pharmaceutical company, Sun Pharma, has witnessed a technical breakdown as its share price dropped below a critical support level. This movement suggests a potential period of volatility and short-term pressure for retail investors holding the stock.
Shift to Pharma and Metals: Expert Advice as Global Tensions Ease
Market veteran Sudip Bandyopadhyay suggests investors pivot toward defensive sectors like pharmaceuticals and healthcare. As geopolitical risks in West Asia soften, focus is shifting to sectors with clear earnings visibility and industrial growth potential.
Dabur Under Lens After US FDA Issues Import Alert on Silvassa Plant Products
Shares of Dabur India are in the spotlight following a US FDA import alert on drugs produced at its Silvassa facility. The regulatory action stems from data integrity concerns, though the company maintains that the impact on overall business is minimal.
Sun Pharma Stock Dips: Is This a Buying Opportunity or Sector Warning?
India's largest pharmaceutical company, Sun Pharma, has witnessed a notable decline in its share price over the past month. Investors are now weighing whether this dip represents a value-buying chance or signals a broader slowdown in the pharma sector.
Sun Pharma Shares See Short-Term Dip: What Retail Investors Need to Know
India's pharmaceutical giant, Sun Pharmaceutical Industries, has experienced a performance cooling over the last month. This dip is significant for retail investors as it directly impacts the valuation of major blue-chip portfolios and sectoral mutual funds.
Kotak Mutual Fund Invests ₹612 Crore in Emcure Pharma; PE Firm BC Investments Exits
Private equity firm BC Investments IV has sold its stake in Emcure Pharmaceuticals to Kotak Mutual Fund for ₹612 crore. This major transaction highlights growing institutional confidence in Emcure's growth potential across key medical segments.
Big Win for Ajanta Pharma as Mutual Fund Giants Buy Shares Worth ₹1,024 Crore
Promoters of Ajanta Pharma have offloaded shares worth over ₹1,024 crore in a massive block deal. Leading institutional investors, including Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund, have stepped in to pick up the stake, signaling strong long-term confidence in the drugmaker.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.